X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (773) 773
Publication (79) 79
Government Document (45) 45
Book Chapter (9) 9
Book Review (4) 4
Dissertation (3) 3
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
heregulin (629) 629
humans (452) 452
animals (288) 288
oncology (272) 272
female (225) 225
biochemistry & molecular biology (222) 222
breast cancer (210) 210
cell biology (198) 198
index medicus (183) 183
expression (182) 182
phosphorylation (173) 173
mice (148) 148
signal transduction (142) 142
receptor, erbb-2 - metabolism (132) 132
neu differentiation factor (127) 127
cell line, tumor (111) 111
neuregulin-1 - metabolism (111) 111
receptor, erbb-3 - metabolism (107) 107
cells (106) 106
ligands (105) 105
activation (103) 103
receptor, erbb-4 (100) 100
tumor cells, cultured (100) 100
neuregulin (97) 97
breast neoplasms - pathology (92) 92
breast neoplasms - metabolism (91) 91
epidermal growth factor (91) 91
growth (88) 88
neuregulins (88) 88
male (87) 87
receptor (82) 82
rats (81) 81
receptor, epidermal growth factor - metabolism (81) 81
cancer (80) 80
neurosciences (77) 77
epidermal growth-factor (76) 76
erbb3 (76) 76
immunohistochemistry (75) 75
differentiation (74) 74
neuregulin-1 - genetics (74) 74
proteins (74) 74
tyrosine kinase (73) 73
molecular sequence data (72) 72
breast-cancer (71) 71
genetics & heredity (70) 70
growth-factor receptor (68) 68
proliferation (68) 68
breast neoplasms - genetics (67) 67
erbb2 (67) 67
protein (67) 67
gene expression (66) 66
neuregulin-1 - pharmacology (62) 62
receptor, erbb-2 - genetics (61) 61
epidermal-growth-factor (60) 60
breast-cancer cells (58) 58
erbb receptors (58) 58
transfection (58) 58
amino acid sequence (57) 57
egf receptor (57) 57
receptors (57) 57
gene expression regulation, neoplastic (56) 56
receptor, erbb-3 (56) 56
ligand (55) 55
growth-factor (54) 54
cell line (53) 53
cardiac development (51) 51
cells, cultured (51) 51
research (51) 51
metastasis (50) 50
her3 (49) 49
proto-oncogene proteins - metabolism (49) 49
apoptosis (48) 48
multidisciplinary sciences (48) 48
factor receptor (47) 47
phosphatidylinositol 3-kinase (47) 47
signal transduction - drug effects (47) 47
skin and connective tissue diseases (47) 47
article (46) 46
erbb receptors - metabolism (46) 46
middle aged (46) 46
protein binding (46) 46
receptor, erbb-3 - genetics (46) 46
tumors (45) 45
tyrosine (45) 45
blotting, western (44) 44
kinases (44) 44
family (43) 43
gene (43) 43
genes (43) 43
adult (42) 42
cell proliferation (41) 41
dimerization (41) 41
signal-transduction (41) 41
research article (40) 40
tyrosine phosphorylation (40) 40
analysis (39) 39
biophysics (39) 39
cell division - drug effects (39) 39
neuregulin-1 (39) 39
neuregulin-1 - physiology (39) 39
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Neurochemistry, ISSN 0022-3042, 08/2001, Volume 78, Issue 3, pp. 552 - 559
The neuregulins, and the ErbB family of tyrosine kinase receptors, play important roles in the development of the nervous system. Recently, the C-terminal... 
heregulin
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 10/2000, Volume 20, Issue 20, pp. 7622 - 7630
Neuregulins have been implicated in a number of events in cells in the oligodendrocyte lineage, including enhanced survival, mitosis, migration, and... 
heregulin
Journal Article
Oncogene, ISSN 0950-9232, 05/2005, Volume 24, Issue 23, pp. 3759 - 3773
Journal Article
by Ren, J and Bharti, A and Raina, D and Chen, W and Ahmad, R and Kufe, D
Oncogene, ISSN 0950-9232, 01/2006, Volume 25, Issue 1, pp. 20 - 31
The MUC1 heterodimeric transmembrane glycoprotein is aberrantly overexpressed by most human carcinomas. The MUC1 C-terminal subunit localizes to mitochondria... 
HSP90 | c-Src | Mitochondria | MUC1 | HSP70 | Heregulin
Journal Article
British Journal of Cancer, ISSN 0007-0920, 02/2002, Volume 86, Issue 4, pp. 540 - 545
Journal Article
by Yao, J and Xiong, S and Klos, K and Nguyen, N and Grijalva, R and Li, P and Yu, D
Oncogene, ISSN 0950-9232, 12/2001, Volume 20, Issue 56, pp. 8066 - 8074
Journal Article
Cellular Signalling, ISSN 0898-6568, 12/2018, Volume 52, pp. 23 - 34
The interplay of ErbB receptor homo- and heterodimers plays a crucial role in the pathology of breast cancer since activated signal transduction cascades... 
Signal transduction | Breast cancer | ErbB receptors | EGF | β-Heregulin
Journal Article
Molecular Cancer Research, ISSN 1541-7786, 01/2019, Volume 17, Issue 1, pp. 20 - 29
The regulation of colorectal cancer cell survival pathways remains to be elucidated. Previously, it was demonstrated that endothelial cells (EC) from the liver... 
CETUXIMAB | STEM-CELLS | ONCOLOGY | PHOSPHORYLATION | KINASE | METASTASES | FLUOROURACIL | EXPRESSION | PROGRESSION | HEREGULIN | ERBB RECEPTORS | CELL BIOLOGY
Journal Article
European Journal of Cancer, ISSN 0959-8049, 12/2019, Volume 123, pp. 36 - 47
The fully human monoclonal antibody patritumab blocks HER3 activation, a resistance mechanism to cetuximab, induced by heregulin (HRG). A phase Ib study in... 
Recurrence | Squamous cell carcinoma of the head and neck | Patritumab | Clinical trial | Metastatic | Phase II | Heregulin | Cetuximab
Journal Article
Breast cancer research : BCR, ISSN 1465-542X, 08/2018, Volume 20, Issue 1, pp. 98 - 1
After the publication of this work [1], an error was noticed in Fig. 2b and Fig. 4b as well as Fig. 4b. and Fig. 5d. Images of the ERK1/2 blots were... 
Journal Article
The Prostate, ISSN 0270-4137, 07/2012, Volume 72, Issue 10, pp. 1140 - 1149
Journal Article
Journal Article
The Oncologist, ISSN 1083-7159, 08/2019, Volume 24, Issue 8, pp. 1095 - 1102
Background Seribantumab (MM‐121) is a fully human IgG2 monoclonal antibody that binds to human epidermal growth factor receptor 3 (HER3/ErbB3) to block... 
Seribantumab | Antibody | Targeted therapy | Biomarkers | HER3/ErbB3 | Heregulin | Translational | ErbB3 | RECEPTOR | OVARIAN-CANCER | PLATINUM-RESISTANT | PACLITAXEL | CETUXIMAB | ONCOLOGY | PATRITUMAB | HER3
Journal Article